| Predicate |
Object |
| contentType |
Journal Article |
| endingPage |
73 |
| issn |
1178-203X |
| pageRange |
265-73 |
| publicationName |
Therapeutics and Clinical Risk Management |
| startingPage |
265 |
| hasFundingAgency |
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_199db1bef4b0308c0639203aa0befa4f |
| isSupportedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_144615a1af182eca41f62c45f3883b2e |
| bibliographicCitation |
Davis B, Bernstein JA. Conestat alfa for the treatment of angioedema attacks. Ther Clin Risk Manag. 2011;7():265–73. PMID: 21753889; PMCID: PMC3132097. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8f2d58e32d065296e0ddcff5f6509a9f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_72cd49555fa747a6d55b16f44c6d1072 |
| date |
201107 |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/PMC3132097
https://doi.org/10.2147/tcrm.s15544
https://pubmed.ncbi.nlm.nih.gov/21753889 |
| isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/33049
https://portal.issn.org/resource/ISSN/1178-203X |
| language |
English |
| source |
https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
Conestat alfa for the treatment of angioedema attacks |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11042
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6903
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7317
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_1f72b6b1ad45ad201b8bec29b3dc6a4d |